News & Updates

CymaBay Therapeutics Presents Positive Final Results From 52-Week Phase 2 Study in Primary Biliary Cholangitis at The Digital International Liver Congress™ 2020

09/01/2020

Excerpt from the Press Release: NEWARK, Calif., Aug. 27, 2020 (GLOBE NEWSWIRE) — CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a biopharmaceutical company focused on developing and providing access to innovative therapies for patients with liver and other chronic diseases, today announced final results from a previously completed open-label Phase 2 study of seladelpar in patients with…

Read More

Synchron’s Stentrode Brain-Computer Interface Receives Breakthrough Device Designation from FDA

08/31/2020

Excerpt from the Press Release: SAN FRANCISCO & NEW YORK & MELBOURNE, Australia–(BUSINESS WIRE)–Synchron, a neurovascular bioelectronics medicine company, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device designation for Stentrode, a fully-implantable medical device that can translate brain activity or stimulate the nervous system from the inside of a…

Read More

Sorrento Announces FDA IND Filing Today for COVI-GUARD Neutralizing and High Potency Antibody Against SARS-CoV-2

08/28/2020

Excerpt from the Press Release: SAN DIEGO, Aug. 19, 2020 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) announced that it is filing an investigational new drug application (IND) for COVI-GUARD (STI-1499) for hospitalized COVID-19 patients today. Sorrento has previously received guidance from the FDA in response to a pre-IND meeting package and believes…

Read More

Karyopharm’s Founder, Sharon Shacham, PhD, Selected as a Finalist for the EY Entrepreneur Of The Year® 2020 Award

08/27/2020

Excerpt from the Press Release: NEWTON, Mass., Aug. 21, 2020 /PRNewswire/ — Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, congratulates its founder, President and Chief Scientific Officer, Sharon Shacham, PhD, MBA, for being selected as a finalist in the EY Entrepreneur of the Year 2020 New England Awards Program. For more…

Read More

This Black Doctors Group Is Making COVID-19 Testing More Accessible

08/26/2020

Excerpt from the article: The coronavirus has hit Black communities across the U.S. so hard that the numbers have stopped doctors in their tracks. In Philadelphia, where 42% of the population is Black and 41% is white, Black people are nearly three times more likely than white people to have the coronavirus. An appalling 52% of COVID-19 deaths in…

Read More

Silicon Valley Startup Exo Secures $40M in Series B+ Funding to Advance Handheld Medical Imaging

08/25/2020

Excerpt from the Press Release: REDWOOD CITY, Calif.–(BUSINESS WIRE)–Exo (pronounced “echo”), a pioneering health information and devices company, closed a $40 million Series B+ funding round that will fund research and product development on a revolutionary handheld medical device and cloud-based workflow software platform. Medical imaging technology has lagged far behind the needs of today’s…

Read More

ForDoz Pharma partners with Lupin on development of 2 complex injectable products

08/24/2020

Excerpt from the Press Release: EAST WINDSOR, N.J., Aug. 20, 2020 (GLOBE NEWSWIRE) — ForDoz Pharma has entered into an agreement with Lupin, to market and distribute 2 complex injectable products in advanced development stage at ForDoz, in US and its territories. The products are in the Oncology and Anti-infective therapeutic areas which when approved,…

Read More

Kaiser to launch Phase 3 testing of coronavirus vaccine in 1,400 California and Oregon adults

08/21/2020

Excerpt from the Press Release: Kaiser Permanente has joined a Phase 3 clinical trial to test a coronavirus vaccine candidate currently in production by Pfizer and BioNTech, and will seek to enroll 1,400 adults aged 18-85 in California and Oregon to join in the study, a press release from the medical organization states. The aim…

Read More

Ask Us Anything – Pharmacovigilance

08/20/2020

This is our second meeting in our ongoing series titled “Ask us Anything – in Clincal Trials”. In this meeting we were fortunate to host our guests from JSS Research and their Pharmacovigilance team. We had a great time discussing the importance of Pharmacovigilance within the clinical trial process. If you’d like to catch the…

Read More

Quidel’s Lyra® Direct SARS-CoV-2 Assay Receives Health Canada Authorization

08/20/2020

Excerpt from the Press Release: SAN DIEGO–(BUSINESS WIRE)–Quidel Corporation (NASDAQ: QDEL) (“Quidel”),a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that Quidel has received Health Canada authorization to market and sell the Lyra® Direct SARS-CoV-2 Assay in Canada. (IO315563, COVID-19 Medical Device Authorization for Importation or Sale; 07/20/2020)…

Read More

Request Your Demo Today!

From rapid database build through database lock, we deliver consistent quality on-time and on-budget. Ready to upgrade your eClinical toolkit?

Archives